Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial.

Vormittag, L

Re-irradiation combined with capecitabine in locally recurrent squamous cell carcinoma of the head and neck. A prospective phase II trial. [electronic resource] - Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] Mar 2012 - 235-42 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article

1439-099X

10.1007/s00066-011-0040-9 doi


Adult
Aged
Antimetabolites, Antineoplastic--therapeutic use
Capecitabine
Carcinoma, Squamous Cell--drug therapy
Combined Modality Therapy--adverse effects
Deoxycytidine--analogs & derivatives
Female
Fluorouracil--analogs & derivatives
Head and Neck Neoplasms--drug therapy
Humans
Male
Middle Aged
Mucositis--etiology
Neoplasm Recurrence, Local--drug therapy
Radiotherapy--adverse effects
Squamous Cell Carcinoma of Head and Neck
Survival Analysis
Treatment Outcome
Young Adult